clinical trial · NCT05607095
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
Uveal MelanomaMelanomaMetastatic Uveal MelanomaMetastatic MelanomaLifileucel (LN-144/LN-145)
brief summary
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.
started
Nov 1, 2022
primary completion
May 1, 2026
completion
May 1, 2026
last updated
Feb 4, 2026
official title
A Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144 or LN-145) for Patients With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol